Study Evaluating Gemtuzumab Ozogamicin in Acute Myeloid Leukemia

NCT00037596 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Gemtuzumab Ozogamicin
DRUG: cytarabine.

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer